Tissue factor around dermal vessels has bound factor VII in the absence of injury

被引:64
作者
Hoffman, M.
Colina, C. M.
McDonald, A. G.
Arepally, G. M.
Pedersen, L.
Monroe, D. M.
机构
[1] Durham Vet Adm Med Ctr, Pathol & Lab Med Serv 113, Durham, NC 27705 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Univ N Carolina, Chapel Hill, NC USA
关键词
hemostasis; immunohistochemistry; initiation of coagulation; skin; tissue factor;
D O I
10.1111/j.1538-7836.2007.02576.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background 'Idling' or ongoing low-level activity of the tissue factor (TF) pathway is a postulated mechanism by which the coagulation process can become active without a lag period at sites of injury. Objective: To determine whether TF around cutaneous vessels has bound factor VIIa in the absence of injury, and thus could participate in the idling process. Methods: Immunostaining of mouse skin with antibodies against a 15-residue peptide from the sequence of mouse TF, and against the whole extracellular portion of TF. Results: The whole TF antibody recognized TF in squamous epithelium and around vessels in the dermis. By contrast, the monospecific antibody only recognized TF in the squamous epithelium, but not around vessels. We also found that biotinylated, active site-inhibited FVIIa (FVIIai) bound to tissue sections in the same areas in which TF was recognized by the monospecific antibody (squamous epithelium), but did not bind around vessels. Molecular modeling revealed that FVIIa and FX binding to TF masked a significant part of the surface of the target peptide. Conclusions: In the aggregate, these data are most consistent with the interpretation that TF in perivascular sites has bound FVIIa, even in the absence of any injury. The presence of endogenously bound FVIIa prevents the subsequent binding of the monospecific antibody or exogenous FVIIai to perivascular TF.
引用
收藏
页码:1403 / 1408
页数:6
相关论文
共 27 条
[1]   Disulfide isomerization switches tissue factor from coagulation to cell signaling [J].
Ahamed, Jasimuddin ;
Versteeg, Henri H. ;
Kerver, Marjolein ;
Chen, Vivien M. ;
Mueller, Barbara M. ;
Hogg, Philip J. ;
Ruf, Wolfram .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (38) :13932-13937
[2]   The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor [J].
Banner, DW ;
DArcy, A ;
Chene, C ;
Winkler, FK ;
Guha, A ;
Konigsberg, WH ;
Nemerson, Y ;
Kirchhofer, D .
NATURE, 1996, 380 (6569) :41-46
[3]  
BAUER KA, 1989, BLOOD, V74, P2007
[4]   BINDING OF HUMAN FACTOR-VII AND FACTOR-VIIA TO MONOCYTES [J].
BROZE, GJ .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (03) :526-535
[5]   COAGULANT PROTEINS AND THROMBIN GENERATION IN SYNOVIAL-FLUID - A MODEL FOR EXTRAVASCULAR COAGULATION [J].
CHANG, P ;
ARONSON, DL ;
BORENSTEIN, DG ;
KESSLER, CM .
AMERICAN JOURNAL OF HEMATOLOGY, 1995, 50 (02) :79-83
[6]   Evidence for activation of tissue factor by an allosteric disulfide bond [J].
Chen, Vivien M. ;
Ahamed, Jasimuddin ;
Versteeg, Henri H. ;
Berndt, Michael C. ;
Ruf, Wolfram ;
Hogg, Philip J. .
BIOCHEMISTRY, 2006, 45 (39) :12020-12028
[7]   What causes the enhancement of activity of factor VIIa by tissue factor? [J].
Colina, C. M. ;
Venkateswarlu, D. ;
Duke, R. ;
Perera, L. ;
Pedersen, L. G. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (12) :2726-2729
[8]  
CONTRINO J, 1994, AM J PATHOL, V145, P1315
[9]   In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease [J].
Contrino, J ;
Hair, G ;
Kreutzer, DL ;
Rickles, FR .
NATURE MEDICINE, 1996, 2 (02) :209-215
[10]  
Dackiw APB, 1996, ARCH SURG-CHICAGO, V131, P1273